Skip to content

Clinical trials

Phase 3 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 3 Clear all

125 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20016
20026
20036
200413
200513
200614
20075
20087
20093
20104
20112
20134
20141
20154
20163
20173
20181
20192
20202
20211
20222
20233
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed94
Terminated11
Recruiting8
Unknown status5
Not yet recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.9
Otsuka Pharmaceutical Development & Commercialization, Inc.9
AstraZeneca7
Corcept Therapeutics6
Janssen, LP6
Karuna Therapeutics, Inc., a Bristol Myers Squibb company3
Organon and Co3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Sumitomo Pharma America, Inc.3
University of Oxford3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders125
Schizophrenia85
Bipolar Disorder14
Mental Disorders14
Major Depressive Disorder11
Alzheimer Disease6
Mania5
Dementia4
Psychomotor Agitation4
Anxiety Disorders2

Trials

Showing 51 to 75 of 125. Each trial links to its page on Pharma Observatory.

25 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.